Cargando…

Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report

BACKGROUND: The development of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis has been reported. Most of the reported cases are mild, with quick clinical recovery and excellent short-term outcomes. Cases of COVID-19 vaccine-associated myocarditis presenting with sustained ventric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojo, Amole, Goldenberg, Ilan, Kutyifa, Valentina, Aktas, Mehmet K., Rosero, Spencer, Ayinde, Hakeem, Huang, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113094/
https://www.ncbi.nlm.nih.gov/pubmed/37082660
http://dx.doi.org/10.21037/atm-22-4164
_version_ 1785027752705916928
author Ojo, Amole
Goldenberg, Ilan
Kutyifa, Valentina
Aktas, Mehmet K.
Rosero, Spencer
Ayinde, Hakeem
Huang, David T.
author_facet Ojo, Amole
Goldenberg, Ilan
Kutyifa, Valentina
Aktas, Mehmet K.
Rosero, Spencer
Ayinde, Hakeem
Huang, David T.
author_sort Ojo, Amole
collection PubMed
description BACKGROUND: The development of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis has been reported. Most of the reported cases are mild, with quick clinical recovery and excellent short-term outcomes. Cases of COVID-19 vaccine-associated myocarditis presenting with sustained ventricular tachycardia (VT) are rare. CASE DESCRIPTION: A 46-year-old male patient with no prior cardiac history presented following two episodes of syncope. Two days earlier, he had received his second dose of COVID-19 mRNA vaccine (Pfizer)—first dose was administered three weeks earlier. He had an episode of VT while in the emergency room. His cardiac magnetic resonance imaging (MRI) findings were consistent with myocarditis. He was eventually diagnosed with COVID-19 vaccine-associated myocarditis after all other work up were unremarkable [echocardiogram, coronary angiogram, diagnostic electrophysiology study and later (18)F-fluorodeoxyglucose (FDG) metabolism cardiac sarcoid positron emission tomography (PET) study]. An implantable cardiac monitor was implanted to monitor for recurrence of VT. Seven months after initial presentation, he had recurrent VT and he underwent implantation of an implantable cardioverter defibrillator (ICD). He has received appropriate ICD therapies on account of recurrent VT and he is currently maintained on an antiarrhythmic medication. CONCLUSIONS: Excellent short-term outcomes have been reported in patients with COVID-19 vaccine associated myocarditis. Our case shows that long-term outcomes may not be benign in everyone, particularly in those who develop myocardial scar.
format Online
Article
Text
id pubmed-10113094
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-101130942023-04-19 Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report Ojo, Amole Goldenberg, Ilan Kutyifa, Valentina Aktas, Mehmet K. Rosero, Spencer Ayinde, Hakeem Huang, David T. Ann Transl Med Case Report BACKGROUND: The development of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis has been reported. Most of the reported cases are mild, with quick clinical recovery and excellent short-term outcomes. Cases of COVID-19 vaccine-associated myocarditis presenting with sustained ventricular tachycardia (VT) are rare. CASE DESCRIPTION: A 46-year-old male patient with no prior cardiac history presented following two episodes of syncope. Two days earlier, he had received his second dose of COVID-19 mRNA vaccine (Pfizer)—first dose was administered three weeks earlier. He had an episode of VT while in the emergency room. His cardiac magnetic resonance imaging (MRI) findings were consistent with myocarditis. He was eventually diagnosed with COVID-19 vaccine-associated myocarditis after all other work up were unremarkable [echocardiogram, coronary angiogram, diagnostic electrophysiology study and later (18)F-fluorodeoxyglucose (FDG) metabolism cardiac sarcoid positron emission tomography (PET) study]. An implantable cardiac monitor was implanted to monitor for recurrence of VT. Seven months after initial presentation, he had recurrent VT and he underwent implantation of an implantable cardioverter defibrillator (ICD). He has received appropriate ICD therapies on account of recurrent VT and he is currently maintained on an antiarrhythmic medication. CONCLUSIONS: Excellent short-term outcomes have been reported in patients with COVID-19 vaccine associated myocarditis. Our case shows that long-term outcomes may not be benign in everyone, particularly in those who develop myocardial scar. AME Publishing Company 2023-02-20 2023-03-31 /pmc/articles/PMC10113094/ /pubmed/37082660 http://dx.doi.org/10.21037/atm-22-4164 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Case Report
Ojo, Amole
Goldenberg, Ilan
Kutyifa, Valentina
Aktas, Mehmet K.
Rosero, Spencer
Ayinde, Hakeem
Huang, David T.
Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title_full Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title_fullStr Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title_full_unstemmed Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title_short Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
title_sort recurrent ventricular tachycardia in a patient with covid-19 vaccine-associated myocarditis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113094/
https://www.ncbi.nlm.nih.gov/pubmed/37082660
http://dx.doi.org/10.21037/atm-22-4164
work_keys_str_mv AT ojoamole recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT goldenbergilan recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT kutyifavalentina recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT aktasmehmetk recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT roserospencer recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT ayindehakeem recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport
AT huangdavidt recurrentventriculartachycardiainapatientwithcovid19vaccineassociatedmyocarditisacasereport